Synapse - Matthew Milowsky

Search Within

Matthew I Milowsky

Results (76)

Phase ii study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer

Journal Article

Balar, A. V.; Apolo, A. B.; Ostrovnaya, I.; Mironov, S.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Milowsky, M. I.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy

Journal Article

Apolo, A. B.; Ostrovnaya, I.; Halabi, S.; Iasonos, A.; Philips, G. K.; Rosenberg, J. E.; Riches, J.; Small, E. J.; Milowsky, M. I.; Bajorin, D. F.
JNCI: Journal of the National Cancer Institute (2013)

Fulltext@MSK | Save

Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC)

Meeting Abstract

Balar, A. V.; Iyer, G.; Al-Ahmadie, H.; Janakiraman, M.; Ostrovnaya, I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Bochner, B.; Bajorin, D. F.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Association of single-nucleotide polymorphisms in BCL2L1 and TACC3 with response to bacillus Calmette-Guerin intravesical therapy in non-muscle-invasive bladder cancer

Meeting Abstract

Alanee, S.; Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Genome sequencing identifies a basis for everolimus sensitivity

Journal Article

Iyer, G.; Hanrahan, A. J.; Milowsky, M. I.; Al-Ahmadie, H.; Scott, S. N.; Janakiraman, M.; Pirun, M.; Sander, C.; Socci, N. D.; Ostrovnaya, I.; more...
Science (2012)

Fulltext@MSK | Save

Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer

Journal Article

Gallagher, D. J.; Cronin, A. M.; Milowsky, M. I.; Morris, M. J.; Bhatia, J.; Scardino, P. T.; Eastham, J. A.; Offit, K.; Robson, M. E.
BJU International (2012)

Fulltext@MSK | Save

Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)

Meeting Abstract

Tagawa, S. T.; Saran, A.; Akhtar, N. H.; Goel, S.; Mileo, G.; Kung, S.; Beltran, H.; Milowsky, M. I.; Mazumdar, M.; Wright, J. J.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium

Meeting Abstract

Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Al-Ahmadie, H.; Ostrovnaya, I.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A multicenter, open-label phase II trial of dovitinib (TKI258) in advanced urothelial carcinoma patients with either mutated or wild-type FGFR3

Meeting Abstract

Milowsky, M. I.; Carlson, G. L.; Shi, M. M.; Urbanowitz, G.; Zhang, Y.; Sternberg, C. N.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Association of germ-line variation with platinum-based chemotherapy response in patients (pts) with urothelial carcinoma (UC)

Meeting Abstract

Gallagher, D. J.; Joseph, V.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; Milowsky, M. I.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save